Atlas Trials

Dyne Therapeutics

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Dyne Therapeutics

RecordFirmDate
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) (NCT07608432)Dyne Therapeutics2026-06-01
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 (NCT07486934)Dyne Therapeutics2026-05-14
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 (NCT05481879)Dyne Therapeutics2022-09-05
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping (NCT05524883)Dyne Therapeutics2022-08-12

Track Dyne Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.